Edition:
United States

U.S. FDA approves Pfizer's Mylotarg for treatment of acute myeloid leukemia


Friday, 1 Sep 2017 11:11am EDT 

Sept 1 (Reuters) - U.S. Food and Drug Administration::U.S. FDA approves Pfizer's Mylotarg for treatment of acute myeloid leukemia.Prescribing information for Mylotarg includes a boxed warning that severe or fatal liver damage occurred in some patients who took mylotarg​.Also approved Mylotarg for patients aged 2 years, older with CD33-positive AML experiencing relapse/ who have not responded to initial treatment​.